Unibest 优贝德
← Back to patent-cliff list

CAS 763114-04-1

tert-butyl 4-(2-fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoyl)piperazine-1-carboxylate

Codes:OLAP-008

Application context (from source-drug indications)

子宫内膜癌奥拉帕利去势抵抗性前列腺肿瘤奥拉帕利前列腺癌奥拉帕利腹膜癌奥拉帕利卵巢上皮癌奥拉帕利输卵管癌奥拉帕利

Source drugs (routes using this intermediate)

DrugTierExpiry
奥拉帕利OlaparibTier A — Act now2028

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.

SupplierProductPrice bandMOQLead timeQualifications
Unibest Nantong cGMP Site2-Fluoro-5-formylbenzonitrile
Pharmaceutical Intermediates
询价询价询价
—
Unibest Taizhou GMP-like Site2-Fluoro-5-[(3-oxo-1(3H)-isobenzofuranylidene)methyl]benzonitrile
Pharmaceutical Intermediates
询价询价询价
—
Qualified Partner — East China API Works2-fluoro-5-((4-oxo-3,4-dihydrophthalazin -1-yl)Methyl)benzoic acid
Pharmaceutical Intermediates
询价询价询价
—
Unibest Nantong cGMP Site1-(Cyclopropylcarbonyl)piperazine hydrochloride
Pharmaceutical Intermediates
询价询价询价
—
Unibest Taizhou GMP-like Site3-oxo-1,3-dihydroisobenzofuran-1-ylphosphonic acid
Pharmaceutical Intermediates
询价询价询价
—

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.